Top insider buys: Jan 29 – Feb 4, 2024

The largest open-market purchases company insiders reported on SEC Form 4 between Jan 29 – Feb 4, 2024.

Week 5, 2024

#	Company	Who bought	Shares	Value	Source
1	RLMD RELMADA THERAPEUTICS, INC.	3 officers/directors Cluster buy Sergio Traversa, Maged Shenouda, Chuck Ence	171,645	$663K	SEC filings
2	COLB COLUMBIA BANKING SYSTEM, INC.	4 officers/directors Cluster buy Luis Machuca, Christopher Merrywell, Clint Stein, John F. Schultz	27,948	$580K	SEC filings
3	TBBK Bancorp, Inc.	2 officers/directors Cluster buy Matthew Cohn, Daniela Mielke	5,603	$253K	SEC filings
4	RCUS Arcus Biosciences, Inc.	10% Owner GILEAD SCIENCES, INC.	15,238,095	$320.0M	SEC filings
5	LSXMK Liberty Media Corp	10% Owner BERKSHIRE HATHAWAY INC	1,827,682	$55.4M	SEC filings
6	NCDL Nuveen Churchill Direct Lending Corp.	10% Owner TEACHERS INSURANCE & ANNUITY ASSOCIATION OF AMERICA	1,662,050	$30.0M	SEC filings
7	WVE Wave Life Sciences Ltd.	10% Owner GSK plc	3,300,000	$16.5M	SEC filings
8	SKYE Skye Bioscience, Inc.	10% Owner 5AM Partners VII, LLC	5,206,074	$12.0M	SEC filings
9	CRBP Corbus Pharmaceuticals Holdings, Inc.	10% Owner Cormorant Asset Management, LP	282,632	$9.1M	SEC filings
10	BMEZ BlackRock Health Sciences Term Trust	10% Owner Saba Capital Management, L.P.	493,733	$7.6M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.